Report for Odaka H

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure - Asakawa_2009_Life.Sci_85_122
Author(s) : Asakawa T , Moritoh Y , Kataoka O , Suzuki N , Takeuchi K , Odaka H
Ref : Life Sciences , 85 :122 , 2009
Abstract : Asakawa_2009_Life.Sci_85_122
ESTHER : Asakawa_2009_Life.Sci_85_122
PubMedSearch : Asakawa_2009_Life.Sci_85_122
PubMedID: 19427871

Title : The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob\/ob mice - Moritoh_2009_Eur.J.Pharmacol_602_448
Author(s) : Moritoh Y , Takeuchi K , Asakawa T , Kataoka O , Odaka H
Ref : European Journal of Pharmacology , 602 :448 , 2009
Abstract : Moritoh_2009_Eur.J.Pharmacol_602_448
ESTHER : Moritoh_2009_Eur.J.Pharmacol_602_448
PubMedSearch : Moritoh_2009_Eur.J.Pharmacol_602_448
PubMedID: 19038243

Title : Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob\/ob mice - Moritoh_2008_Eur.J.Pharmacol_588_325
Author(s) : Moritoh Y , Takeuchi K , Asakawa T , Kataoka O , Odaka H
Ref : European Journal of Pharmacology , 588 :325 , 2008
Abstract : Moritoh_2008_Eur.J.Pharmacol_588_325
ESTHER : Moritoh_2008_Eur.J.Pharmacol_588_325
PubMedSearch : Moritoh_2008_Eur.J.Pharmacol_588_325
PubMedID: 18499100